D. E. Shaw & Co., Inc. Neogenomics Inc Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 39,909 shares of NEO stock, worth $397,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,909

Previous 59,728 33.18%

Holding current value

$397,094

Previous $880,000 25.34%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$13.0 - $18.43 $257,647 - $365,264	-19,819 Reduced 33.18%	39,909 $657,000
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $1.43 Million - $1.89 Million	-106,828 Reduced 64.14%	59,728 $880,000
Q2 2024 Aug 14, 2024	BUY	$13.01 - $15.77 $276,696 - $335,396	21,268 Added 14.64%	166,556 $2.31 Million
Q1 2024 May 15, 2024	SELL	$14.06 - $16.79 $3.5 Million - $4.18 Million	-248,891 Reduced 63.14%	145,288 $2.28 Million
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $4.46 Million - $7.92 Million	-382,283 Reduced 49.23%	394,179 $6.38 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $1.43 Million - $2.1 Million	-117,493 Reduced 13.14%	776,462 $9.55 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $986,633 - $1.39 Million	69,974 Added 8.49%	893,955 $14.4 Million
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $1.49 Million - $3.19 Million	-164,198 Reduced 16.62%	823,981 $14.3 Million
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $2.29 Million - $4.28 Million	354,978 Added 56.06%	988,179 $9.13 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $2.95 Million - $4.85 Million	-375,885 Reduced 37.25%	633,201 $5.45 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $6.92 Million - $13.7 Million	979,787 Added 3344.1%	1,009,086 $8.22 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $240,594 - $698,614	19,802 Added 208.51%	29,299 $356,000
Q1 2021 May 17, 2021	SELL	$41.56 - $59.88 $828,664 - $1.19 Million	-19,939 Reduced 67.74%	9,497 $458,000
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $1.06 Million - $1.66 Million	29,436 New	29,436 $1.59 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $336,591 - $409,657	-10,120 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $245,005 - $313,922	10,120 New	10,120 $314,000
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $202,872 - $319,288	-10,700 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $204,584 - $280,768	10,700 New	10,700 $205,000
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $4.05 Million - $6.83 Million	-333,609 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $3.19 Million - $5.26 Million	284,201 Added 575.21%	333,609 $4.21 Million
Q3 2018 Nov 14, 2018	SELL	$12.5 - $15.38 $273,750 - $336,822	-21,900 Reduced 30.71%	49,408 $758,000
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $569,750 - $1 Million	71,308 New	71,308 $935,000

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.25B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account